| MeSH term | MeSH ID | Detail |
|---|---|---|
| Diarrhea | D003967 | 32 associated lipids |
| Pain | D010146 | 64 associated lipids |
| Abscess | D000038 | 13 associated lipids |
| Fractures, Spontaneous | D005598 | 4 associated lipids |
| Osteomyelitis | D010019 | 10 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Intraoperative Complications | D007431 | 5 associated lipids |
| Drug Hypersensitivity | D004342 | 20 associated lipids |
| Hyperbilirubinemia | D006932 | 11 associated lipids |
| Anaphylaxis | D000707 | 35 associated lipids |
Rifamycin SV
Rifamycin SV is a lipid of Polyketides (PK) class. Rifamycin sv is associated with abnormalities such as Cholestasis, Infection, Dysentery, Soft Tissue Infections and Osteomyelitis. The involved functions are known as Uptake, Excretory function, Drug Kinetics, inhibitors and anaphylaxis. Rifamycin sv often locates in Hepatic, Blood, soluble, Entire gastrointestinal tract and Membrane. The associated genes with Rifamycin SV are SLCO1C1 gene, SLCO1B1 gene, ABCB11 gene and SLC10A1 gene.
Cross Reference
Introduction
To understand associated biological information of Rifamycin SV, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Rifamycin SV?
Rifamycin SV is suspected in Tuberculosis, Cholestasis, Infection, Dysentery, Soft Tissue Infections, Osteomyelitis and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Rifamycin SV
PubChem Associated disorders and diseases
What pathways are associated with Rifamycin SV
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Rifamycin SV?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Rifamycin SV?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Rifamycin SV?
There are no associated biomedical information in the current reference collection.
What genes are associated with Rifamycin SV?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Rifamycin SV?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Rifamycin SV
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid: | ||||
| Bi YA et al. | Reliable Rate Measurements for Active and Passive Hepatic Uptake Using Plated Human Hepatocytes. | 2017 | AAPS J | pmid:28188574 |
| Peng WT et al. | Bacterial type I glutamine synthetase of the rifamycin SV producing actinomycete, Amycolatopsis mediterranei U32, is the only enzyme responsible for glutamine synthesis under physiological conditions. | 2006 | Acta Biochim. Biophys. Sin. (Shanghai) | pmid:17151776 |
| Yu H et al. | Identification and characterization of glnA promoter and its corresponding trans-regulatory protein GlnR in the rifamycin SV producing actinomycete, Amycolatopsis mediterranei U32. | 2006 | Acta Biochim. Biophys. Sin. (Shanghai) | pmid:17151777 |
| Zhang Y et al. | GlnR positive transcriptional regulation of the phosphate-specific transport system pstSCAB in Amycolatopsis mediterranei U32. | 2018 | Acta Biochim. Biophys. Sin. (Shanghai) | pmid:30007316 |
| Yuan H et al. | Two genes, rif15 and rif16, of the rifamycin biosynthetic gene cluster in Amycolatopsis mediterranei likely encode a transketolase and a P450 monooxygenase, respectively, both essential for the conversion of rifamycin SV into B. | 2011 | Acta Biochim. Biophys. Sin. (Shanghai) | pmid:21986914 |
| Kawde AN et al. | Adsorptive stripping voltammetry of antibiotics rifamycin SV and rifampicin at renewable pencil electrodes. | 2014 | Acta Chim Slov | pmid:25125124 |
| González CI et al. | Reverse transcriptase-like activity in Trypanosoma cruzi. | 1997 | Acta Trop. | pmid:9088425 |
| Singh R et al. | No impact of rifamycin selection on tuberculosis treatment outcome in HIV coinfected patients. | 2013 | AIDS | pmid:23014518 |
| Antonicelli L et al. | IgE-mediated reactions to rifaximin and rifamycin SV and cross-reactivity among rifamycins. | 2009 | Allergy | pmid:19416136 |
| Craven N and Anderson JC | Antibiotic activity against intraleukocytic Staphylococcus aureus in vitro and in experimental mastitis in mice. | 1983 | Am. J. Vet. Res. | pmid:6553464 |
| Iselin F et al. | [Comparative study of the effects of a local antibiotic and a local antiseptic in emergency hand surgery]. | 1990 | Ann Chir Main Memb Super | pmid:2346354 |
| Revuz J et al. | [Generalization of zona in a nonimmunosuppressed patient receiving isoprinosine and rifamycin SV]. | 1983 | Ann Dermatol Venereol | pmid:6195953 |
| Hanzlik J et al. | [Clinical evaluation of rifamycin SV in ampules of 250 and 500 mg produced by the Tarchomin Pharmaceutical Plants "Polfa"]. | 1986 | Ann Univ Mariae Curie Sklodowska Med | pmid:3154057 |
| Erel F et al. | Severe anaphylaxis from rifamycin SV. | 1998 | Ann. Allergy Asthma Immunol. | pmid:9759804 |
| Caruso I et al. | Rheumatoid knee synovitis successfully treated with intra-articular rifamycin SV. | 1982 | Ann. Rheum. Dis. | pmid:7046652 |
| Maggi N et al. | New derivatives of rifamycin SV. | 1965 | Antimicrob Agents Chemother (Bethesda) | pmid:4956802 |
| Kradolfer F et al. | Chemotherapeutic activity of new derivatives of rifamycin. | 1966 | Antimicrob Agents Chemother (Bethesda) | pmid:5985258 |
| Farrell DJ et al. | In vitro activity and single-step mutational analysis of rifamycin SV tested against enteropathogens associated with traveler's diarrhea and Clostridium difficile. | 2011 | Antimicrob. Agents Chemother. | pmid:21149623 |
| Di Stefano AF et al. | Systemic absorption of rifamycin SV MMX administered as modified-release tablets in healthy volunteers. | 2011 | Antimicrob. Agents Chemother. | pmid:21402860 |
| Mariner KR et al. | Furanyl-rhodanines are unattractive drug candidates for development as inhibitors of bacterial RNA polymerase. | 2010 | Antimicrob. Agents Chemother. | pmid:20660693 |
| KLUEPFEL D et al. | METABOLISM OF BARBITAL BY STREPTOMYCES MEDITERRANEI. | 1965 | Appl Microbiol | pmid:14339268 |
| MARGALITH P and PAGANI H | Rifomycin. XIV. Production of rifomycin B. | 1961 | Appl Microbiol | pmid:13766661 |
| THIEMANN JE et al. | RIFAMYCIN. XXXIV. PHYSICOCHEMICAL CHARACTERIZATION OF ACTINOPHAGES ACTIVE ON STREPTOMYCES MEDITERRANEI. | 1964 | Appl Microbiol | pmid:14170965 |
| THIEMANN JE et al. | RIFAMYCIN. XXXIII. ISOLATION OF ACTINOPHAGES ACTIVE ON STREPTOMYCES MEDITERRANEI AND CHARACTERISTICS OF PHAGE-RESISTANT STRAINS. | 1964 | Appl Microbiol | pmid:14167333 |
| MARGALITH P and PAGANI H | Rifomycin. XIII. Fermentation and production of rifomycin complex. | 1961 | Appl Microbiol | pmid:13766660 |
| Zhang W et al. | Molecular analysis and heterologous expression of the gene encoding methylmalonyl-coenzyme A mutase from rifamycin SV-producing strain Amycolatopsis mediterranei U32. | 1999 | Appl. Biochem. Biotechnol. | pmid:10813025 |
| Wang W et al. | MoeA, an enzyme in the molybdopterin synthesis pathway, is required for rifamycin SV production in Amycolatopsis mediterranei U32. | 2002 | Appl. Microbiol. Biotechnol. | pmid:12382055 |
| Nagavalli M et al. | Enhanced rifamycin SV production by submerged fermentation using Amycolatopsis mediterranei. | 2015 | Appl. Microbiol. Biotechnol. | pmid:26026938 |
| Kukiełka E and Cederbaum AI | Stimulation of microsomal production of reactive oxygen intermediates by rifamycin SV: effect of ferric complexes and comparisons between NADPH and NADH. | 1992 | Arch. Biochem. Biophys. | pmid:1329662 |
| Wang W et al. | Molecular and biochemical characterization of a novel two-component signal transduction system, amrA- amkA, involved in rifamycin SV production in Amycolatopsis mediterranei U32. | 2002 | Arch. Microbiol. | pmid:12375106 |
| Shao Z et al. | Identification and functional analysis of a nitrate assimilation operon nasACKBDEF from Amycolatopsis mediterranei U32. | 2011 | Arch. Microbiol. | pmid:21424691 |
| Yu H et al. | A complex role of Amycolatopsis mediterranei GlnR in nitrogen metabolism and related antibiotics production. | 2007 | Arch. Microbiol. | pmid:17364194 |
| Magdalan J et al. | Comparative antidotal efficacy of benzylpenicillin, ceftazidime and rifamycin in cultured human hepatocytes intoxicated with α-amanitin. | 2009 | Arch. Toxicol. | pmid:19730819 |
| Yang L et al. | An eukaryotic-type serine/threonine protein kinase involved in the carbon source-dependent pigment biosynthesis in Amycolatopsis mediterranei U32. | 2001 | Biochem. Biophys. Res. Commun. | pmid:11394886 |
| Kukiełka E and Cederbaum AI | Stimulation of NADH-dependent microsomal DNA strand cleavage by rifamycin SV. | 1995 | Biochem. J. | pmid:7733870 |
| Quinlan GJ and Gutteridge JM | DNA base damage by beta-lactam, tetracycline, bacitracin and rifamycin antibacterial antibiotics. | 1991 | Biochem. Pharmacol. | pmid:1930286 |
| Eichler HG et al. | Studies on the uptake of low molecular weight monomeric tris-galactosyl conjugates by the rat liver. | 1992 | Biochem. Pharmacol. | pmid:1472076 |
| Quinlan GJ and Gutteridge JM | Oxygen radical damage to DNA by rifamycin SV and copper ions. | 1987 | Biochem. Pharmacol. | pmid:2823829 |
| Fardel O et al. | Rifampicin enhances anti-cancer drug accumulation and activity in multidrug-resistant cells. | 1995 | Biochem. Pharmacol. | pmid:7763306 |
| Sáez GT et al. | Effect of metal ion catalyzed oxidation of rifamycin SV on cell viability and metabolic performance of isolated rat hepatocytes. | 1991 | Biochim. Biophys. Acta | pmid:2049402 |
| Passamonti S and Sottocasa GL | The quinoid structure is the molecular requirement for recognition of phthaleins by the organic anion carrier at the sinusoidal plasma membrane level in the liver. | 1988 | Biochim. Biophys. Acta | pmid:3401473 |
| Chernov AP et al. | Recombinant reverse transcriptase of Rous sarcoma virus: characterization of DNA polymerase and RNAase H activities. | 1991 | Biomed. Sci. | pmid:1717011 |
| Deshko TN et al. | [Physico-chemical properties of DNA-dependent RNA-polymerase from Escherichia coli and its subunits]. | 1984 | Bioorg. Khim. | pmid:6388581 |
| Li J et al. | Preparation and in vitro anti-staphylococcal activity of novel 11-deoxy-11-hydroxyiminorifamycins. | 2007 | Bioorg. Med. Chem. Lett. | pmid:17826091 |
| Kumar S et al. | Synthesis and biological evaluation of trans 6-methoxy-1,1-dimethyl-2-phenyl-3-aryl-2,3-dihydro-1H-inden-4-yloxyalkylamine derivatives against drug susceptible, non-replicating M. tuberculosis H37Rv and clinical multidrug resistant strains. | 2013 | Bioorg. Med. Chem. Lett. | pmid:23474387 |
| Knight JL et al. | Distance-restrained docking of rifampicin and rifamycin SV to RNA polymerase using systematic FRET measurements: developing benchmarks of model quality and reliability. | 2005 | Biophys. J. | pmid:15542547 |
| Krishna PS et al. | Biosynthesis of rifamycin SV by Amycolatopsis mediterranei MTCC17 in solid cultures. | 2003 | Biotechnol. Appl. Biochem. | pmid:12546705 |
| Chen L et al. | Cloning and preliminary characterization of lh3 gene encoding a putative acetyltransferase from a rifamycin SV-producing strain Amycolatopsis mediterranei. | 2005 | Biotechnol. Lett. | pmid:16132864 |
| Chiao JS et al. | Rifamycin SV and related ansamycins. | 1995 | Biotechnology | pmid:8688635 |
| Gentile S et al. | [Influence of allopurinol on the half-life of tolbutamide and rifamycin-SV in blood of healthy volunteers]. | 1979 | Boll. Soc. Ital. Biol. Sper. | pmid:552849 |
| Spisani S et al. | [Effect of rifamycin SV on neutrophil functions in patients with rheumatoid arthritis]. | 1981 | Boll. Soc. Ital. Biol. Sper. | pmid:7236419 |
| Ebo DG et al. | Perioperative anaphylaxis from locally applied rifamycin SV and latex. | 2006 | Br J Anaesth | pmid:16698868 |
| SHILO M | THE USE OF LEVAN-ENHANCED DERMAL INFECTIONS IN RABBITS IN THE STUDY OF IN VIVO ACTIVITY OF ANTIBIOTIC SUBSTANCES. | 1964 | Br J Exp Pathol | pmid:14140754 |
| Courtois A et al. | Inhibition of multidrug resistance-associated protein (MRP) activity by rifampicin in human multidrug-resistant lung tumor cells. | 1999 | Cancer Lett. | pmid:10408915 |
| Medoff G et al. | Potentiation of rifampicin, rifampicin analogs, and tetracycline against animal cells by amphotericin B and polymyxin B. | 1973 | Cancer Res. | pmid:4352361 |
| Aygün F et al. | The protective effect of topical rifamycin treatment against sternal wound infection in diabetic patients undergoing on-pump coronary artery bypass graft surgery. | 2014 May-Jun | Cardiovasc J Afr | pmid:24687038 |
| Zhao W et al. | Complete genome sequence of the rifamycin SV-producing Amycolatopsis mediterranei U32 revealed its genetic characteristics in phylogeny and metabolism. | 2010 | Cell Res. | pmid:20567260 |
| Alonso Lomillo MA et al. | Resolution of binary mixtures of rifamycin SV and rifampicin by UV/VIS spectroscopy and partial least-squares method (PLS). | 2004 | Chem. Biodivers. | pmid:17191911 |
| Calatayud M et al. | In vitro study of transporters involved in intestinal absorption of inorganic arsenic. | 2012 | Chem. Res. Toxicol. | pmid:22214486 |
| Pyta K et al. | Regioselective long-range proton transfer in new rifamycin antibiotics: a process in which crown ethers act as stronger Brønsted bases than amines. | 2015 | Chemphyschem | pmid:25639734 |
| Setti G et al. | The treatment of idiopathic and secondary hydrarthrosis of the knee by intra-articular Rifamycin SV. | 1990 Oct-Dec | Chir Organi Mov | pmid:2098221 |
| Nettles RE et al. | Risk factors for relapse and acquired rifamycin resistance after directly observed tuberculosis treatment: a comparison by HIV serostatus and rifamycin use. | 2004 | Clin. Infect. Dis. | pmid:14986259 |
| Gentile S et al. | The implication of bilitranslocase function in the impaired rifamycin SV metabolism in Gilbert's syndrome. | 1985 | Clin. Sci. | pmid:2485269 |
| Mancuso G and Masarà N | Contact urticaria and severe anaphylaxis from rifamycin SV. | 1992 | Contact Derm. | pmid:1395622 |
| Testa A et al. | Preclinical Evaluation of [F]LCATD as a PET Tracer to Study Drug-Drug Interactions Caused by Inhibition of Hepatic Transporters. | 2018 | Contrast Media Mol Imaging | pmid:30154685 |
| Wang W et al. | A novel two-component system amrB-amkB involved in the regulation of central carbohydrate metabolism in rifamycin SV-producing Amycolatopsis mediterranei U32. | 2004 | Curr. Microbiol. | pmid:15018097 |
| Chen C et al. | Differential interaction of 3-hydroxy-3-methylglutaryl-coa reductase inhibitors with ABCB1, ABCC2, and OATP1B1. | 2005 | Drug Metab. Dispos. | pmid:15616150 |
| Mita S et al. | Inhibition of bile acid transport across Na+/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs. | 2006 | Drug Metab. Dispos. | pmid:16760228 |
| Garver E et al. | Involvement of intestinal uptake transporters in the absorption of azithromycin and clarithromycin in the rat. | 2008 | Drug Metab. Dispos. | pmid:18755851 |
| Zhang W et al. | A novel transmembrane serine/threonine protein kinase gene from a rifamycin SV-producing amycolatopsis mediterranei U32. | 2000 | Eur. J. Biochem. | pmid:10848993 |
| Persico M et al. | The association between rifamycin-SV (R-SV) related hyperbilirubinaemia and antipyrine clearance as a new test of liver function in cirrhosis. | 1994 | Eur. J. Clin. Invest. | pmid:8033955 |
| Renoult E et al. | Effect of topical rifamycin SV treatment on cyclosporin A blood levels in a renal transplant recipient. | 1991 | Eur. J. Clin. Pharmacol. | pmid:2050183 |
| Lin SW et al. | Rifamycin SV MMX for the treatment of traveler's diarrhea. | 2017 | Expert Opin Pharmacother | pmid:28697313 |
| Quinn FR | The quantitative structure-activity relationship of rifamycin B amide and hydrazide toxicity in mice. | 1982 | Farmaco Sci | pmid:7056391 |
| Nikiforov VG et al. | A derivative of rifamycin SV inhibiting rifampicin-resistant RNA polymerase of Escherichia coli. | 1982 | FEBS Lett. | pmid:6761147 |
| Muñiz P et al. | The role of 8-hydroxy-2'-deoxyguanosine in rifamycin-induced DNA damage. | 1995 | Free Radic. Biol. Med. | pmid:7750799 |
| Michelson AM | Pro-oxidant action of superoxide dismutase in the autoxidation of rifamycin SV. | 1986 | Free Radic. Res. Commun. | pmid:2577735 |
| Sáez GT et al. | The role of glutathione in protection against DNA damage induced by rifamycin SV and copper(II) ions. | 1993 | Free Radic. Res. Commun. | pmid:8225041 |
| Fernandes D and Giacinti F | [Agranulocytosis induced by rifamycin SV in a patient with Hodgkin's disease. Immunologic considerations and pathogenetic interpretations]. | 1982 Jan-Jun | G Batteriol Virol Immunol | pmid:7187341 |
| Marchi E et al. | [New derivatives of rifamycin SV. Esters, hydrazide amides of 3-carboxyrifamycin SV]. | 1979 Jan-Dec | G Ital Chemioter | pmid:554811 |
| Okolicsanyi L et al. | [Effect of rifamycin SV on the metabolism of bile salts in the rat]. | 1979 Jan-Dec | G Ital Chemioter | pmid:554815 |
| Byrne JA et al. | The human bile salt export pump: characterization of substrate specificity and identification of inhibitors. | 2002 | Gastroenterology | pmid:12404239 |
| Stieger B et al. | Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. | 2000 | Gastroenterology | pmid:10648470 |
| Zhang W et al. | Sequence analysis and expression of the aspartokinase and aspartate semialdehyde dehydrogenase operon from rifamycin SV-producing amycolatopsis mediterranei. | 1999 | Gene | pmid:10521665 |
| Kenwright S and Levi AJ | Sites of competition in the selective hepatic uptake of rifamycin-SV, flavaspidic acid, bilirubin, and bromsulphthalein. | 1974 | Gut | pmid:4842968 |
| Radossi P et al. | Intra-articular rifamycin in haemophilic arthropathy. | 2003 | Haemophilia | pmid:12558780 |
| Nitti V | The antituberculous activity of rifamycin SV. | 1965 | Helv Med Acta | pmid:4958120 |
| Gentile S et al. | Impaired plasma clearance of nicotinic acid and rifamycin-SV in Gilbert's syndrome: evidence of a functional heterogeneity. | 1985 | Hepatogastroenterology | pmid:4018705 |
| Gentile S et al. | Plasma clearance of nicotinic acid and rifamycin-SV, and their interaction in Gilbert's syndrome: application of a compartmental model. | 1984 | Hepatogastroenterology | pmid:6724499 |
| Noe J et al. | Characterization of the mouse bile salt export pump overexpressed in the baculovirus system. | 2001 | Hepatology | pmid:11343252 |
| Fattinger K et al. | Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2. | 2000 | Hepatology | pmid:10869292 |
| Vavricka SR et al. | Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver. | 2002 | Hepatology | pmid:12085361 |
| Yu WH et al. | [Study of incompatibility in vitro of injection of rifamycin sodium with 45 injections]. | 1986 | Hua Xi Yi Ke Da Xue Xue Bao | pmid:3804311 |
| Amagai T et al. | The effect of ribavirin and rifamycin SV on age-dependent changes of the immune system during the adult life of SJL mice. | 1982 | Immunol. Lett. | pmid:6210629 |
| Spisani S et al. | 3-(Carboxyalkylthio) rifamycin S and SV derivatives inhibit human neutrophil functions. | 1998 | Inflammation | pmid:9793793 |
| Gurel MS et al. | Comparison of the effects of topical fusidic acid and rifamycin on wound healing in rats. | 2015 | Int Wound J | pmid:23489386 |
| Rosette C et al. | Anti-inflammatory and immunomodulatory activities of rifamycin SV. | 2013 | Int. J. Antimicrob. Agents | pmid:23756321 |
| Narang SS et al. | Molecular insights into the inhibitory mechanism of rifamycin SV against β-microglobulin aggregation: A molecular dynamics simulation study. | 2017 | Int. J. Biol. Macromol. | pmid:28455257 |
| Scala E et al. | Multiple drug allergy syndrome: severe anaphylactic reaction due to topical rifamycin SV in a patient with hypersensitivity to ciprofloxacin. | 2001 | Int. J. Dermatol. | pmid:11737462 |